Back to results
US 2004/0176406 A1Published application
Pyrido [2,1-a] isoquinoline derivatives
AssigneeHoffmann-La Roche Inc.
InventorsLuca Claudio Gobbi, Thomas Luebbers, Patrizio Mattei, Robert Narquizian, Pierre Charles Wyss
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of formula (I) 1 wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Claims18
A ompound of formula (I)
- 11
- wherein
- R1 is lower alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, or lower alkyl substituted by cycloalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl;
- R2, R3 and R4 are each independently hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy or lower alkenyl, wherein lower alkyl, lower alkoxy and lower alkenyl are optionally substituted by lower alkoxycarbonyl, aryl, substituted aryl, heterocyclyl or substituted heterocyclyl.
- R5 is hydrogen, fluorine, lower alkyl, aryl or substituted aryl;
- R6 is hydrogen, lower alkyl or hydroxy-lower alkyl, or
- R5 and R6 together with the carbon atoms to which they are attached form a five or six membered saturated carbocyclic ring;
- R7 is hydrogen, fluorine or lower alkyl;
- and pharmaceutically acceptable salts thereof;
- with the exception of rac-3β-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11bβ-hexahydro-2H-pyrido[2,1-a]isoquinolin-2β-ylamine dihydrochloride and rac-3β-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11bβ-hexahydro-2H-pyrido[2,1-a]isoquinolin-2α-ylamine dihydrochloride.
7 more elements
Dependencies are inferred from the claim text.